Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
Acute neck is very common in the general population and often causes disability over shorter or longer time periods. Unfortunately, the efficacy of chiropractic spinal manipulative therapy (CSMT) and the efficacy of Non-steroidal Anti-inflammatory Drugs (NSAIDs) on acute neck pain is unknown. This 4-arm randomized controlled trial (RCT) will likely provide evidence for the efficacy of CSMT as well as NSAIDs. The applied methodology of the study will aim towards the highest research standards possible for manual-therapy RCTs, thus avoiding typical methodological shortcomings from previous manual-therapy studies. Our aim is to establish evidence-based knowledge on the efficacy of CSMT and NSAIDs in the treatment of acute neck pain.
Full description
The Global Burden of Disease study ranks musculoskeletal neck pain as the most common disability worldwide. This study will highlight and validate CSMT for acute neck pain, compared to sham manipulation, ibuprofen and placebo medication. NSAIDs are the most frequently prescribed medications by GPs worldwide and are widely used for patients with back pain. However, evidence-based data are missing for acute neck pain patients treated with NSAIDs while existing evidence for CSMT for acute neck pain are limited by serious methodological shortcomings.
The 4-arm placebo-controlled RCT will assess the efficacy in the following four treatment groups:
We intend to invite 40 recruiting chiropractors from larger Norwegian cities, distributed by gender and geography. The study participants presenting to each chiropractor will be block-randomized equally into one of four study groups based on a computer-generated algorithm. Each chiropractor will include 16 participants, four into each arm. A total of 320 participants will be enrolled in the RCT, within 12 months. Participants randomized into the chiropractic treatment groups will receive 5 interventions over 12 days, i.e., CSMT or CSMT sham manipulation; while the pharmacological groups will receive 600mg ibuprofen or placebo administered 3 times daily for 12 days.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion criteria
Exclusion criteria
Contraindication to ibuprofen
Taken pain- and/or anti-inflammatory medicine during the past 24 hours? (Patients that have taken acute pain- and/or anti-inflammatory medicine, including ibuprofen, can be included if they come back after 24 hours without having taken the medicine where they then fill out questionnaires and are randomized at the clinic)
On prescribed antidepressant
Major psychiatric disorder
Pregnancy or intention to be pregnant
Contraindication to SMT
Signs of spinal radiculopathy including progressive neurological deficit
Upper cervical spine instability (positive Sharp-Purser test)
Previous fracture in the cervical and/or thoracic spine
Previous cervical spine surgery
Recent (<6 months) severe physical trauma to the head, neck or thoracic spine within the previous 6 months
Concomitant low back pain with moderate, severe or very severe pain intensity (≥4 on a NRS)
Current chronic pain (defined as ≥3 months duration)
Rheumatoid arthritis
Recent (<2 weeks) acute respiratory infection with fever
Any presence of ischemic symptoms upon examination
Horner's syndrome
Medical history of arterial anomalies
History of connective tissue disorder
Familial history of cervical artery dissection
Other vascular disorders
Inability to understand instructions given in the Norwegian language
Inability to fill out digital questionnaires
Other reasons to exclude the patient as deemed necessary by the chiropractor
Primary purpose
Allocation
Interventional model
Masking
320 participants in 4 patient groups
Loading...
Central trial contact
Michael B. Russell, Professor; Anna J. Allen-Unhammer, PhD student
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal